Ignite Creation Date:
2025-12-17 @ 9:17 PM
Ignite Modification Date:
2025-12-23 @ 11:09 PM
Study NCT ID:
NCT00744874
Status:
None
Last Update Posted:
2018-09-19 00:00:00
First Post:
2008-08-28 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ablation of the Pulmonary Veins for Paroxysmal Afib
Sponsor:
None
Organization:
Study Overview
Official Title:
Multi-Array Ablation of the Pulmonary Veins for Paroxysmal Atrial Fibrillation
Status:
None
Status Verified Date:
2018-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MAP-PAF
Brief Summary:
This trial was a non-randomized, multi-center, prospective study of subjects with symptomatic, paroxysmal atrial fibrillation (PAF). The purpose of this study was to investigate and confirm the safety, efficacy and efficiency of the Medtronic Ablation Frontiers® Cardiac Ablation System when used for the treatment of paroxysmal AF. The trial was conducted over a 2 year period with enrollment occurring between 4 October 2007 and 1 December 2008.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: